BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 18312775)

  • 1. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
    Maron BJ; Maron MS; Lesser JR; Hauser RG; Haas TS; Harrigan CJ; Appelbaum E; Main ML; Roberts WC
    Am J Cardiol; 2008 Feb; 101(4):544-7. PubMed ID: 18312775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
    Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Fananapazir L
    Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
    J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
    Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asystole and scarring of the interventricular septum in hypertrophic cardiomyopathy.
    Foley PW; Frenneaux MP; Leyva F
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):349-51. PubMed ID: 19430348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].
    Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L
    Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK; Camm AJ
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular fibrillation during sleep in an adolescent with hypertrophic cardiomyopathy: the difficulty of risk stratification and the power of the cardioverter-defibrillator.
    Boriani G; Biffi M; Rapezzi C; Coccolo F; Branzi A; Spirito P
    Int J Cardiol; 2004 Oct; 97(1):143-4. PubMed ID: 15336824
    [No Abstract]   [Full Text] [Related]  

  • 16. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy with two episodes of recuperated sudden death. Report of the first implantable defibrillator cardioverter inserted in Chile].
    Zalaquett R; Fajuri A; Irarrázaval MJ; Neghme R; Vergara I; Sacco C; Dubernet J; Corbalán R
    Rev Med Chil; 1994 Oct; 122(10):1171-7. PubMed ID: 7659885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertrophic cardiomyopathy. Arrhythmia in hypertrophic cardiomyopathy].
    Colín Lizalde Lde J
    Arch Cardiol Mex; 2003; 73 Suppl 1():S26-30. PubMed ID: 12966640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.